An early donor of the research that led to the Moderna COVID-19 vaccine, Hill believes that "science is the answer"—and has chosen to donate the entirety of her estate to philanthropy and scientific research.
MORE►
pegasus park
Lyda Hill [Photo: Carnegie Medal of Philanthropy]
Dallas Philanthropist Lyda Hill Is One of Five Winners of the Carnegie Medal of Philanthropy
by Lance Murray | Aug 4, 2022
Dallas' Lyda Hill has been named one of five recipients of the 2022 Carnegie Medal of Philanthropy. She shares the philanthropic spotlight with four other "forces for positive change," including country music legend Dolly Parton.
An early donor of the research that led to the Moderna COVID-19 vaccine, Hill believes that "science is the answer"—and has chosen to donate the entirety of her estate to philanthropy and scientific research.
An early donor of the research that led to the Moderna COVID-19 vaccine, Hill believes that "science is the answer"—and has chosen to donate the entirety of her estate to philanthropy and scientific research.
by Sandra Engelland |
Aug 3, 2022
Top North Texas healthcare and life science employers—including UT Southwestern, McKesson, Evolve Biologics, Texas Health Resources, and more—have already signed up to hire 1,100 biotech workers from the groundbreaking program.
27,000 workers have made Dallas-Fort Worth a Top 20 U.S. metro for life sciences companies. As the boom continues, they’ll need company. Here's how the grant will help Dallas College and other local higher ed institutions step up to provide it—and why a CEO at Lyda Hill Philantrhopies calls it a "game changer."
27,000 workers have made Dallas-Fort Worth a Top 20 U.S. metro for life sciences companies. As the boom continues, they’ll need company. Here's how the grant will help Dallas College and other local higher ed institutions step up to provide it—and why a CEO at Lyda Hill Philantrhopies calls it a "game changer."
MORE►
by David Seeley |
Jun 30, 2022
At the 2022 BIO International Conference in San Diego, representatives from North Texas met "the greatest minds in biotechnology"—and discovered some of them are interested in relocating their companies to DFW.
"We connected with them to explore opportunities and increase investments in the Dallas region,” said a VP with the Dallas Regional Chamber.
"We connected with them to explore opportunities and increase investments in the Dallas region,” said a VP with the Dallas Regional Chamber.
MORE►
by Kevin Cummings |
Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases.
With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE►
Pegasus artwork in the lobby of Dallas' Pegasus Park, the home of the ARPA-H Customer Experience Hub. [Photo: Dallas Innovates]
Center of Gravity: Capital Factory Kicks Off New Dallas Digs With Startup Crawl and Health Supernova Event
by Kevin Cummings | May 6, 2022
Earlier this week, the Austin-based accelerator and investor announced its plans to launch a Center for Health Innovation at Pegasus Park in Dallas.
MORE►
by Kevin Cummings |
May 5, 2022
The Austin-based accelerator and investor plans to launch its Center for Health Innovation at Pegasus Park in Dallas by end of 2023. Its goal: connecting startups locally and across the state with each other, as well as other corporate and research players in the space.
“We're in the business of erasing boundaries in Texas—full stop,” President and Co-Founder Bryan Chambers told Dallas Innovates.
“We're in the business of erasing boundaries in Texas—full stop,” President and Co-Founder Bryan Chambers told Dallas Innovates.
MORE►
by Dallas Innovates | Staff Report |
Apr 29, 2022
The Advanced Research Projects Agency for Health (ARPA-H) was established last month by the Biden administration with $1 billion in funding to advance biomedical and health research....
MORE►
![Southwestern Medical Foundation President and CEO Kathleen Gibson has joined the board of nonprofit LaunchBio. [Image: Southwestern Medical Foundation; istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2022/04/Kathleen-Gibson-LaunchBio-board-360x203.jpg)
by Quincy Preston |
Apr 29, 2022
LaunchBio, a life science and biotech nonprofit that expanded to North Texas in 2021, has announced four new board members, including Dallas-based Kathleen Gibson, along with a new board chair.
LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
MORE►
[Illustration: ipopba/iStock]
Collaboration Is the Key to North Texas’ Emergence as a Bio-Hub
by Kathleen Otto and George Goodno | Mar 17, 2022
"When it comes to the biotech industry, our region is leading the U.S. in key metrics of job growth and investment," write Kathleen Otto and George Goodno. One proof point? VC funding is flowing into DFW at a faster rate than any other area in the nation.
These North Texas life science leaders say the region's success is no coincidence. Here's how the shared ambition of key players and strategic collaboration has impact.
These North Texas life science leaders say the region's success is no coincidence. Here's how the shared ambition of key players and strategic collaboration has impact.
MORE►
by David Kirkpatrick |
Jan 25, 2022
The accelerator will move this summer from its downtown Dallas location to 6,000 square feet of collaborative and flexible office space in Pegasus Park's 18-story tower.
Just weeks ago, Pegasus Park landed one of its biggest tenants to date: UT Southwestern‘s Office for Technology Development and other UTSW entities will be leasing six floors in the tower.
MORE►
by David Seeley |
Dec 15, 2021
At the free, live, in-person networking event, attendees will hear from the MassChallenge team and key partners about the North Texas launch. The live pitch competition will allow early-stage startups to compete for a direct spot in the MassChallenge 2022 Global Early-Stage Program.
MORE►
by Quincy Preston |
Nov 2, 2021
BioLabs at Pegasus Park shared space and state-of-the-art lab is slated to open in December. It's a place where entrepreneurial innovators can test, develop, and grow their ideas.
MORE►
[Illustration: KrulUA/iStock]
LaunchBio Gets $750K From U.S. Department of Commerce’s $36.5M ‘Build to Scale’ Program
by Alex Edwards | Sep 30, 2021
LaunchBio was one of 50 recipients of the program, which is led and managed by the Office of Innovation and Entrepreneurship at the U.S. Economic Development Administration, to accelerate technology entrepreneurship and fuel innovation. The nonprofit organization's winning three-year proposal focuses on how to coordinate and enhance resources in North Texas to establish the region as a globally recognized entrepreneurial ecosystem. A large part of that is development of the Biotech+ Hub at Pegasus Park.
MORE►
by Alex Edwards |
Aug 10, 2021
A mid-December opening is planned for BioLabs' first central U.S. location in Dallas. Inside the Biotech+ Hub at Pegasus Park, BioLabs will serve as the key operator of the biotech laboratory and 37,000-square-foot flexible life science coworking facility.
MORE►
by Quincy Preston |
Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE►
by Alex Edwards |
Feb 10, 2021
The agreement will involve the two companies providing educational programs and connections for scientist entrepreneurs located at the Biotech+ Hub at Pegasus Park.
MORE►
